Matt Kaye followed Manu Saadia
Manu Saadia
Found the future in Asimov (age 8). Never looked back.
Follow
Matt Kaye followed Nick Scott and Noa Gavin
Nick Scott and Noa Gavin
Readers. Improvisers. Writers. Weirdos. 
Follow
Matt Kaye followed Paul Robinson
Paul Robinson
Reader, Writer, Watcher, Player, Sleeper, Eater.
Follow
Matt Kaye liked an update for Abomination

QUICK UPDATE: Yesterday I spent most of the day at the Inkshares office signing an insane number of hardcover copies. They're all boxed up and ready to go, so we're not gonna wait -- backer copies ship out NEXT WEEK, which means you'll have your signed copy well in advance of the official July 29 publication date. w000t!

Also, I'm really thrilled that Abomination was included in influential sci-fi/fantasy site io9's list of must-read books for July! The article can be found HERE.

Finaly, a brief reminder -- if you like the book, please leave a review/rating on Goodreads as it helps immensely with building traction for the book. The Abomination page on Goodreads is HERE.

Gary

like · liked by Chris and 6 others

People who have liked this reader update

    Matt Kaye followed Gridworld
    Gridworld
    Gridworld
    Gridworld is a planet honeycombed with mining shafts. What are they looking for and what if they find it?
    Matt Kaye followed House of Ibises
    House of Ibises
    House of Ibises
    A contemporary southern gothic novella of a boy whose New Orleans home is overrun by native birds after the hurricane.
    Matt Kaye followed Sean Byrnes
    Sean Byrnes
    I have been writing stories my entire life, based on my enjoyment of reading and my love of creating...
    Follow
    Matt Kaye followed Jack Myers
    Jack Myers
    Jack is the author of The Future of Men: Masculinity in the Twenty-First Century. His TEDWomen Talk ...
    Follow
    Matt Kaye followed Filip Syta
    Filip Syta
    I write about everything that disrupts my mind.
    Follow
    Matt Kaye followed The Show
    The Show
    Silicon Valley - The new Wall Street: sex, drugs and tech.
    More items